WHO approves Sinovac COVID-19 vaccine

Tuesday, 1 June 2021 19:34

By Reuters

The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.

It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.

WHO emergency listing is a signal to national regulators on a product's safety and efficacy.

It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.

In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.

There was no upper age limit as data suggested it is likely to have a protective effect in older people.

More from International News

Race to reach trapped survivors offers hope in Colombia quake zone

Rescuers raced in Colombia on Friday to free four people from a collapsed hotel, a rare sign of hope nearly four days after one of the strongest earthquakes to hit the Andean nation in decades left hundreds dead or missing.
France's top court blocks social media ban for under-15s

France's top court on Friday blocked a bill banning social media access for under-15s, saying it infringed upon freedom of expression and delivering a setback for President Emmanuel Macron, who asked his government to rewrite the legislation.
Japan's record rains strand thousands at Narita airport; kill eight

Record rainfall in Japan stranded thousands of travellers at Tokyo's Narita airport on Friday, bringing floods to the surrounding area that disrupted transport, knocked out power to 20,000 homes and killed eight.
Wildfires in Britain hit record levels after homes burn in intense heat

Wildfires in England and Wales have hit a record level, fire chiefs said on Friday, warning that rescue services were battling to keep up with rising risks a day after fires raced from tinder-dry fields to engulf houses on the hottest day of the year.